Stockscreener 앱 받기
1.405
2.41%
-0.0398
시간 외 거래:
1.40
-0.005
-0.36%
전일 마감가:
$1.4448
열려 있는:
$1.42
하루 거래량:
4,547
Relative Volume:
0.50
시가총액:
$16.61M
수익:
$3.37M
순이익/손실:
$-57.28M
주가수익비율:
-0.1018
EPS:
-13.8
순현금흐름:
$-51.83M
1주 성능:
+1.44%
1개월 성능:
-2.08%
6개월 성능:
-14.55%
1년 성능:
-33.02%
1일 변동 폭
$1.3701
$1.42
1주일 범위
$1.36
$1.4448
52주 변동 폭
$1.22
$5.1181
신로직 Stock (SYBX) Company Profile
명칭
Synlogic Inc
전화
617-659-2802
주소
PO BOX 30, WINCHESTER, MA
SYBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SYBX | 1.405 | 16.61M | 3.37M | -57.28M | -51.83M | -13.80 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
신로직 Stock (SYBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-11-24 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-08-21 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-30 | 개시 | Jefferies | Buy |
| 2018-12-13 | 개시 | Chardan Capital Markets | Buy |
| 2018-03-19 | 개시 | H.C. Wainwright | Buy |
| 2018-01-29 | 개시 | Piper Jaffray | Overweight |
모두보기
신로직 주식(SYBX)의 최신 뉴스
Phenylketonuria Market size is ~700 USD million in 2023, asserts DelveInsight | Pharma Giants: PTC Therapeutics, Homology Medicines, Synlogic, BioMarin Pharmaceuticals - The Globe and Mail
Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023) - Yahoo Finance
Synlogic Reports Q3 2024 Financial Outcomes - TipRanks
Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewswire
Synlogic (SYBX) Slashes Q3 Losses by 99% Amid Strategic Review, No Revenue | SYBX Stock News - StockTitan
Synlogic's head of finance Mary Beth Dooley sells $110 in stock - Investing.com India
Renaissance Technologies LLC Decreases Position in Synlogic, Inc. (NASDAQ:SYBX) - Defense World
5 Best Microbiome Companies (November 2024) - Securities.io
Smartsheet to go private in $8.4 bln deal with PE firms Vista and Blackstone - Reuters
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Stock Holdings Increased by Progeny 3 Inc. - Defense World
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Shares Sold by Shapiro Capital Management LLC - Defense World
Smartsheet to Be Bought in $8.4 Billion Deal. The Stock Is Rising. - Barron's
21,806 Shares in Synaptics Incorporated (NASDAQ:SYNA) Bought by Intech Investment Management LLC - Defense World
Synchronoss Technologies (NASDAQ:SNCR) Shares Cross Above 200-Day Moving Average of $9.72 - Defense World
Syntara Limited Director Boosts Stake - TipRanks
SNBL and SBI Holdings Launch $40M Startup Fund - TipRanks
Smartsheet Is a Smart Buy for Traders and Investors: Here's Why - Benzinga
Where are the Opportunities in (SNCRL) - Stock Traders Daily
STRM’s Debt-to-Equity Ratio at 0.78: What It Means for Streamline Health Solutions, Inc’s Future - The InvestChronicle
Canada Pension Plan Investment Board Acquires 509,700 Shares of Symbotic Inc. (NASDAQ:SYM) - MarketBeat
Gut Microbiota Market Big Changes to Have Big Impact | Ferring, Synlogic - Newstrail
Synlogic (FRA:MIN) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Synlogic (FRA:MIN) Volatility : 59.76% (As of Aug. 15, 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Synlogic, Inc. Boosted by Analyst (NASDAQ:SYBX) - Defense World
Synlogic, Inc. (NASDAQ:SYBX) Sees Large Growth in Short Interest - Defense World
Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewswire
Synlogic (NASDAQ:SYBX) Stock Passes Above 50-Day Moving Average of $1.57 - Defense World
Synlogic Inc expected to post a loss of 51 cents a shareEarnings Preview - XM
Otsuka snaps up Jnana with its phenylketonuria drug for $800m - Pharmaceutical Technology
Synlogic, Inc. (NASDAQ:SYBX) Short Interest Up 22.0% in July - Defense World
Synlogic (NASDAQ:SYBX) Stock Crosses Above Fifty Day Moving Average of $1.57 - Defense World
Synlogic (NASDAQ:SYBX) Shares Cross Above 50-Day Moving Average of $1.58 - Defense World
Synlogic (NASDAQ:SYBX) Stock Price Crosses Below 50 Day Moving Average of $1.61 - Defense World
Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer - Quantisnow
Synlogic Reports Second Quarter 2018 Financial Results and Provides Program Updates - br.ADVFN.com
What Makes Synlogic, Inc. (SYBX) a New Buy Stock - Yahoo New Zealand News
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks - Quantisnow
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors - StockTitan
Why Synlogic (SYBX) Could Be a Potential Winner - Yahoo Singapore News
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Synlogic (NASDAQ:SYBX) Share Price Crosses Below 50 Day Moving Average of $1.76 - Defense World
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership ... - br.ADVFN.com
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Singapore News
The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits - Markets Insider
Synlogic Announces Termination Of Abbvie Collaboration Agreement - Reuters
Leerink Partnrs Analysts Increase Earnings Estimates for Synlogic, Inc. (NASDAQ:SYBX) - Defense World
Synlogic Flat On Q1 Numbers - MENAFN.COM
Synlogic Reports First Quarter 2024 Financial Results - GlobeNewswire
Synlogic Inc expected to post a loss of 82 cents a shareEarnings Preview - XM
Synlogic's head of finance sells shares worth $325 By Investing.com - Investing.com
신로직 (SYBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
신로직 주식 (SYBX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dooley Mary Beth | Head of Finance |
Apr 02 '24 |
Sale |
1.73 |
188 |
325 |
15,231 |
| Awad Antoine | Chief Operating Officer |
Apr 02 '24 |
Sale |
1.73 |
372 |
644 |
33,859 |
0.93%
3.56%
자본화:
|
볼륨(24시간):